Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New carbamate derivative from Kyorin with high affinity/selectivity for M1 receptors

April 10, 1997

New bradykinin B2 antagonist from Fujisawa

April 10, 1997

Pharmacia & Upjohn describes compounds for amyloidosis

April 10, 1997

NMDA antagonist revealed by Sumitomo

April 10, 1997

Selfadministration device for Imitrex available in the U.S.

April 9, 1997

Agents for cerebral ischemia and neurodegenerative disorders from Boehringer Ingelheim

April 9, 1997

NIH licenses method of reducing aminoglycoside-induced hearing loss

April 9, 1997

Gene Logic/Johns Hopkins collaborate on schizophrenia and depression gene discovery

April 8, 1997

PGE2 agonists/antagonists from Ono

April 8, 1997

Novel antiemetic reported by Dainippon

April 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.